Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 950-485-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 20 Oct 2009 to 26 Jan 2010
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Remarks:
- Deviation: The highest concentration tested was based on growth inhibition. The study report does not specify which parameter was used to determine "growth inhibition".
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- adopted 21 July 1997
- Deviations:
- yes
- Remarks:
- The highest concentration tested was based on growth inhibition. The study report does not specify which parameter was used to determine "growth inhibition".
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- 1-{[1-({1-[(2,2-dimethylpropanoyl)oxy]propan-2-yl}oxy)propan-2-yl]oxy}propan-2-yl 2,2-dimethylpropanoate
- Molecular formula:
- C19H36O6
- IUPAC Name:
- 1-{[1-({1-[(2,2-dimethylpropanoyl)oxy]propan-2-yl}oxy)propan-2-yl]oxy}propan-2-yl 2,2-dimethylpropanoate
1
Method
- Target gene:
- his operon (for S. typhimurium) and trp operon (for E. coli)
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- cofactor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of male SD rats treated with phenobarbital and 5,6-benzoflavone
- Test concentrations with justification for top dose:
- 19.5, 78.1, 313, 1250 and 5000 µg/plate (Dose-finding test)
313, 625, 1250, 2500 and 5000 µg/plate (Main test: TA 100 and WP2 uvra +/-S9, TA 98 +S9)
2.44, 4.88, 9.77, 19.5, 39.1 and 78.1 (Main test: 1535 -S9)
9.77, 19.5, 39.1, 78.1, 156 and 313 (Main test: 1537 +/- S9, TA 98 -S9, TA 1535 +S9
Justification for top dose: In the dose-finding experiment growth inhibition was observed at 78.1 µg/plate and above for S. typhimurium TA1535 without metabolic activation, and at 313 µg/plate and above for S. typhimurium TA98 and TA1537 without metabolic activation and for S. typhimurium TA1535 and TA1537 with metabolic activation. The maximum dose level was set at 78.1 µg/plate for S. typhimurium TA1535 without metabolic activation and at 313 µg/plate for S. typhimurium TA98 and TA1537 without metabolic activation and for S. typhimurium TA1535 and TA1537 with metabolic activation and a total of 6 dose levels were selected by diluting five times at a common ratio of two. For S. typhimurium TA100 and E. coli WP2 uvrA without metabolic activation and S. typhimurium TA100, TA98 and E. coli WP2 uvrA with metabolic activation, the maximum dose level was set at 5000 µg/plate and a total of five dose levels obtained by diluting four times at a common ratio of two because no growth inhibition was observed. Precipitates were observed at 1250 µg/plate and above without metabolic activation. - Vehicle / solvent:
- - Vehicle used: DMSO
- Justification for choice of vehicle: Since the test article is insoluble in water, a solubility test in DMSO was performed at the test facility. Based on these results, DMSO was used as the vehicle in this study because the test article was dissolved in DMSO at 50 mg/mL and there were no reactions such as exothermic reaction or generation of gasses.
Controls
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- benzo(a)pyrene
- other: 2-(2-Furyl)-3-(5-nitro-2-furyl)acrylamide (AF-2) , 2-Methoxy-6-chloro-9-[3-(2-chloroethyl)- aminopropylamino]acridine.2HCl (ICR-191) and 2-Aminoanthracene (2AA) solved in DMSO
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: preincubation method
DURATION
- Preincubation period: 20 min
- Exposure duration: 50 h
NUMBER OF REPLICATIONS: triplicates each in two independent experiments
DETERMINATION OF CYTOTOXICITY
- Method: growth inhibition - Rationale for test conditions:
- based on dose-range finding study.
- Evaluation criteria:
- If a twofold or more increase in the number of revertant colonies to that of natural revertant colonies (the negative control) was observed on paralle to a dose-response and reproducibility was noted, or even if no clear dose-response was observed but there was at least twofold increase in comparison with the number of natural revertant colonies and reproducibility was observed in the two main tests, the test article was judged to be positive.
- Statistics:
- Mean numbers and standard deviations of the revertant colonies of each concentration of each test system was calculated and compared to that of the solvent control.
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- growth inhibition at 78.1 and 39. 1 (first and second experiment -S9), 313 and 156 µg/plate (first and second experiment +S9)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- growth inhibition at 313 and 156 µg/plate (first and second experiment +/-S9)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- growth inhibition at 313 and 156 µg/plate (first and second experiment -S9)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: In both the first and second main tests, oily precipitation of the test article on the plate was observed at 1250 μg/plate and above without metabolic activation. Coloration by the test article in the test systems was not observed with or without metabolic activation.
- Cytotoxicity: In the observation of bacteria with a stereoscopic microscope, growth inhibition was observed at 39.1 µg/plate and above for S. typhimurium TA1535 without metabolic activation, at 156 µg/plate and above for S. typhimurium TA98 and TA1537 without metabolic activation and S. typhimurium TA1535 and TA1537 with metabolic activation.
Any other information on results incl. tables
Table 1: Dose-range-finding test (mean)
Compound |
S-9 Mix |
concentration |
TA 100 |
TA 1535 |
WP2 uvra |
TA 98 |
TA 1537 |
DMSO |
- |
0 |
111 |
9 |
23 |
20 |
10 |
Test substance |
- |
5000# |
110 |
8* |
30 |
27* |
5* |
- |
1250# |
97 |
8* |
31 |
31* |
10* |
|
- |
313 |
101 |
7* |
29 |
26* |
8* |
|
- |
78.1 |
114 |
5* |
24 |
23 |
6 |
|
- |
19.5 |
106 |
9 |
31 |
29 |
8 |
|
DMSO |
+ |
|
111 |
9 |
33 |
42 |
7 |
Test substance |
+ |
5000 |
111 |
6* |
31 |
33 |
10* |
+ |
1250 |
106 |
7* |
32 |
38 |
6* |
|
+ |
313 |
104 |
9* |
32 |
42 |
6* |
|
+ |
78.1 |
126 |
12 |
32 |
35 |
7 |
|
+ |
19.5 |
127 |
8 |
25 |
32 |
12 |
|
Positive control |
- |
|
650 (a) |
343 (b) |
79 (a) |
429 (a) |
2081(c) |
Positive control |
+ |
|
1144 (d) |
372 (e) |
895 (e) |
398 (d) |
118 (d) |
a)AF-2:2-(2-Furyl)-3-(5-nitro-2-furyl)acrylamide
b) SAZ:Sodium azide
c) ICR-191:2-Methoxy-6-chloro-9-[3-(2-chloroethyl)-aminopropylamino]acridine.2HCl
d) B[a]P:Benzo[a]pyrene
e) 2AA:2-Aminoanthracene
*:Growth inhibition of tester strains was observed.
#:Precipitant was observed on the surface of agar plates.
Table 2: Results of the first experiment (without S-9)
Compound |
S-9 Mix |
concentration |
TA 100 |
TA 1535 |
WP2 uvra |
TA 98 |
TA 1537 |
DMSO |
- |
0 |
105 ± 4-6 |
8 ± 1.5 |
26 ± 4.7 |
27 ± 3.5 |
7 ± 3.1 |
Test substance |
- |
5000# |
88 ± 10.8 |
NT |
25 ± 2.6 |
NT |
NT |
- |
2500# |
90 ± 4.2 |
NT |
26 ± 4.0 |
NT |
NT |
|
- |
1250# |
96 ± 3.1 |
NT |
35 ± 11.6 |
NT |
NT |
|
- |
625 |
80 ± 14.8 |
NT |
26 ± 7.5 |
NT |
NT |
|
- |
313 |
81 ± 4.4 |
NT |
24 ± 1.5 |
24 ± 3.5* |
4 ± 2.0* |
|
|
156 |
NT |
NT |
NT |
26 ± 2.1* |
4 ± 2.5* |
|
|
78.1 |
NT |
7 ± 4.0* |
NT |
32 ± 1.2 |
5 ± 1.5 |
|
|
39.1 |
NT |
8 ± 4.6* |
NT |
31 ± 3.8 |
7 ± 1.5 |
|
|
19.5 |
NT |
11 ± 1.7 |
NT |
30 ± 5.7 |
6 ± 1.0 |
|
|
9.77 |
NT |
12 ± 2.1 |
NT |
30 ± 10.7 |
5 ± 1.7 |
|
|
4.88 |
NT |
12 ± 5.1 |
NT |
NT |
NT |
|
|
2.44 |
NT |
11 ± 0.6 |
NT |
NT |
NT |
|
Positive control |
- |
|
565 ± 38.5 (a) |
271 ± 38.9 (b) |
83 ± 7.4 (a) |
493 ± 11.5 (a) |
1665 ± 291.5 (c) |
NT: not tested
* growth inhibition
#: Precipitation was observed on the surface of agar plates.
a) 2-(2-Furyl)-3-(5-nitro-2-furyl)acrylamide (AF-2)
b) Sodium azide (SAZ)
c) 2-Methoxy-6-chloro-9-[3-(2-chloroethyl)-aminopropylamino]acridine.2HCl (ICR-191)
Table 3: Results of the first experiment (with S+9)
Compound |
S-9 Mix |
concentration |
TA 100 |
TA 1535 |
WP2 uvra |
TA 98 |
TA 1537 |
DMSO |
+ |
0 |
110 ± 7.5 |
10 ± 1.2 |
26 ± 4.0 |
33 ± 6.1 |
6 ± 1.7 |
Test substance |
+ |
5000 |
98 ± 8.5 |
NT |
27 ± 6.1 |
35 ± 4.9 |
NT |
+ |
2500 |
91 ± 6.0 |
NT |
25 ± 3.1 |
37 ± 7.4 |
NT |
|
+ |
1250 |
93 ± 4.7 |
NT |
26 ± 6.1 |
37 ± 5.0 |
NT |
|
+ |
625 |
102 ± 18 |
NT |
27 ± 0.6 |
38 ± 3.6 |
NT |
|
+ |
313 |
100 ± 8.6 |
NT |
22 ± 5.1 |
34 ± 3.1 |
8 ± 2.0* |
|
|
156 |
NT |
NT |
NT |
NT |
8 ± 0.0* |
|
|
78.1 |
NT |
9 ± 1.2* |
NT |
NT |
7 ± 3.1 |
|
|
39.1 |
NT |
13 ± 1.5* |
NT |
NT |
6 ± 0.6 |
|
|
19.5 |
NT |
8 ± 2.1 |
NT |
NT |
5 ± 2.5 |
|
|
9.77 |
NT |
11 ± 2.5 |
NT |
NT |
7 ± 4.2 |
|
|
4.88 |
NT |
10 ± 1.5 |
NT |
NT |
NT |
|
|
2.44 |
NT |
11 ± 4.4 |
NT |
NT |
NT |
|
Positive control |
+ |
|
1116 ± 55.4(d) |
339 ± 15.5 (e) |
898 ± 20.3(e) |
354 ± 33.0(d) |
98 ± 6.0 (d) |
NT: not tested
* growth inhibition
d) B[a]P:Benzo[a]pyrene
e) 2AA:2-Aminoanthracene
Table 4: Results of the second experiment (without S-9)
Compound |
S-9 Mix |
concentration |
TA 100 |
TA 1535 |
WP2 uvra |
TA 98 |
TA 1537 |
DMSO |
- |
0 |
110 ± 8.6 |
12 ± 3.8 |
16 ± 4.0 |
31 ± 5.1 |
8 ± 1.2 |
Test substance |
- |
5000# |
117 ± 4.6 |
NT |
19 ± 7.6 |
NT |
NT |
- |
2500# |
102 ± 11.6 |
NT |
15 ± 7.5 |
NT |
NT |
|
- |
1250# |
104 ± 12.1 |
NT |
20 ± 6.0 |
NT |
NT |
|
- |
625 |
104 ± 9.1 |
NT |
15 ± 3.5 |
NT |
NT |
|
- |
313 |
100 ± 7.2 |
NT |
14 ± 3.5 |
31 ± 8.4* |
8 ± 3.5* |
|
|
156 |
NT |
NT |
NT |
31 ± 7.6* |
5 ± 4.2* |
|
|
78.1 |
NT |
12 ± 2.1* |
NT |
34 ± 5.3 |
9 ± 2.6 |
|
|
39.1 |
NT |
9 ± 4.0* |
NT |
38 ± 3.5 |
6 ± 1.7 |
|
|
19.5 |
NT |
11 ± 0.6 |
NT |
37 ± 2.9 |
6 ± 1.0 |
|
|
9.77 |
NT |
11 ± 1.5 |
NT |
25 ± 3.5 |
5 ± 0.6 |
|
|
4.88 |
NT |
12 ± 4.2 |
NT |
NT |
NT |
|
|
2.44 |
NT |
13 ± 4.0 |
NT |
NT |
NT |
|
Positive control |
- |
|
624 ± 38.4 (a) |
299 ± 12.9 (b) |
65 ± 1.7 (a) |
497 ± 12.3 (a) |
1541 ± 190.3 (c) |
NT: not tested
* growth inhibition
#: Precipitation was observed on the surface of agar plates.
a) 2-(2-Furyl)-3-(5-nitro-2-furyl)acrylamide (AF-2)
b) Sodium azide(SAZ)
c) 2-Methoxy-6-chloro-9-[3-(2-chloroethyl)-aminopropylamino]acridine.2HCl(ICR-191)
Table 5: The result (mean) of the second experiment (with S-9)
Compound |
S-9 Mix |
concentration |
TA 100 |
TA 1535 |
WP2 uvra |
TA 98 |
TA 1537 |
DMSO |
- |
0 |
99 ± 3.5 |
8 ± 1.5 |
15 ± 4.0 |
42 ± 8.0 |
10 ± 4.0 |
Test substance |
- |
5000 |
108 ± 12.0 |
NT |
19 ± 4.6 |
38 ± 5.3 |
NT |
- |
2500 |
107 ± 9.9 |
NT |
23 ± 2.3 |
40 ± 1.2 |
NT |
|
- |
1250 |
99 ± 4.4 |
NT |
16 ± 4.9 |
33 ± 7.8 |
NT |
|
- |
625 |
112 ± 14.0 |
NT |
15 ± 5.5 |
41 ± 6.6 |
NT |
|
- |
313 |
108 ± 17.1 |
NT |
19 ± 8.1 |
41 ± 11.3 |
7 ± 1.0* |
|
|
156 |
NT |
NT |
NT |
NT |
7 ± 0.0* |
|
|
78.1 |
NT |
9 ± 3.1* |
NT |
NT |
13 ± 2.6 |
|
|
39.1 |
NT |
11 ± 0.6* |
NT |
NT |
7 ± 1.7 |
|
|
19.5 |
NT |
12 ± 3.6 |
NT |
NT |
11 ± 1.0 |
|
|
9.77 |
NT |
9 ± 2.5 |
NT |
NT |
13 ± 2.5 |
|
|
4.88 |
NT |
12 ± 1.0 |
NT |
NT |
NT |
|
|
2.44 |
NT |
12 ± 3.5 |
NT |
NT |
NT |
|
Positive control |
- |
|
1018 ± 35.9 (d) |
357 ± 41.0 (e) |
1141 ± 42.0 (e) |
361 ± 15.6 (d) |
113 ± 3.5 (d) |
NT: not tested
* growth inhibition
d) B[a]P:Benzo[a]pyrene
e) 2AA:2-Aminoanthracene
Applicant's summary and conclusion
- Conclusions:
- Under the conditions of the conducted test, the substance was not mutagenic in any of the five tester strains tested with and without metabolic activation up to 5000 µg/plate or tested up to cytotoxic concentrations.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
